Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 53.07B | 53.10B | 54.23B | 63.05B | 79.02B | 77.87B |
Gross Profit | 15.79B | 17.34B | 21.71B | 26.87B | 43.81B | 43.61B |
EBITDA | 1.11B | 1.20B | 11.24B | 21.30B | 33.87B | 36.12B |
Net Income | -20.50B | -18.76B | 1.69B | 8.01B | 19.87B | 20.90B |
Balance Sheet | ||||||
Total Assets | 192.52B | 196.49B | 191.57B | 182.10B | 168.41B | 153.09B |
Cash, Cash Equivalents and Short-Term Investments | 21.21B | 22.06B | 25.03B | 28.34B | 28.41B | 23.89B |
Total Debt | 50.76B | 50.01B | 49.28B | 42.05B | 38.10B | 36.40B |
Total Liabilities | 86.77B | 91.45B | 81.61B | 78.82B | 73.02B | 72.05B |
Stockholders Equity | 97.88B | 99.27B | 105.59B | 101.42B | 95.39B | 81.04B |
Cash Flow | ||||||
Free Cash Flow | -10.94B | -15.66B | -14.28B | -9.62B | 9.13B | 20.93B |
Operating Cash Flow | 10.08B | 8.29B | 11.47B | 15.43B | 29.46B | 35.38B |
Investing Cash Flow | -8.53B | -18.26B | -24.04B | -10.23B | -24.28B | -20.80B |
Financing Cash Flow | -3.14B | 11.14B | 8.51B | 1.11B | -6.21B | -12.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $4.40T | 58.13 | 115.46% | 0.02% | 86.17% | 81.36% | |
78 Outperform | $288.07B | 102.18 | 4.70% | ― | 27.17% | 108.67% | |
77 Outperform | $1.02T | 27.19 | 33.29% | 1.13% | 38.65% | ― | |
75 Outperform | $114.95B | 63.06 | 5.21% | 1.65% | -6.17% | -14.16% | |
75 Outperform | $129.81B | 19.28 | 35.64% | 1.03% | 6.70% | -5.95% | |
57 Neutral | €1.69B | 12.10 | 1.59% | 3.67% | 2.96% | -106.86% | |
52 Neutral | $107.50B | ― | -19.24% | 0.51% | -3.72% | -2120.70% |
On April 14, 2025, Intel Corporation entered into a transaction agreement to sell a majority interest in its Altera business to SLP VII Gryphon Aggregator, L.P. An amendment to this agreement was made on August 11, 2025, adjusting the purchase price calculations and extending the closing date to September 13, 2025. The transaction is expected to impact Intel’s operations, with potential risks including regulatory approval delays, changes in business relationships, and competition in the semiconductor industry.
In the second quarter of 2025, Intel announced a significant restructuring initiative aimed at simplifying operations, enhancing transparency, and reallocating resources to core business areas. This plan, approved by the Audit Committee on July 10, 2025, includes a 15% reduction in the workforce and is expected to incur $1.9 billion in restructuring charges, primarily recognized in the second quarter. The initiative aims to improve efficiency and financial discipline, with a focus on strengthening Intel’s core product portfolio and AI roadmap. Despite these efforts, Intel reported a flat revenue of $12.9 billion for Q2 2025 and a GAAP EPS loss of $(0.67), impacted by restructuring charges. The company is targeting $17 billion in non-GAAP operating expenses for 2025 and $18 billion in gross capital expenditures.